0001493152-20-012783.txt : 20200821 0001493152-20-012783.hdr.sgml : 20200821 20200707214700 ACCESSION NUMBER: 0001493152-20-012783 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20200707 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DOCUMENT SECURITY SYSTEMS INC CENTRAL INDEX KEY: 0000771999 STANDARD INDUSTRIAL CLASSIFICATION: PAPERBOARD CONTAINERS & BOXES [2650] IRS NUMBER: 161229730 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 200 CANAL VIEW BOULEVARD STREET 2: SUITE 104 CITY: ROCHESTER STATE: NY ZIP: 14623 BUSINESS PHONE: 585 232 1500 MAIL ADDRESS: STREET 1: 200 CANAL VIEW BOULEVARD STREET 2: SUITE 104 CITY: ROCHESTER STATE: NY ZIP: 14623 FORMER COMPANY: FORMER CONFORMED NAME: NEW SKY COMMUNICATIONS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: THOROUGHBREDS USA INC DATE OF NAME CHANGE: 19861118 CORRESP 1 filename1.htm

Document Security Systems, Inc.

200 Canal View Boulevard, Suite 104

Rochester, NY 14623

July 7, 2020

Securities and Exchange Commission

Division of Corporation Finance

Office of Manufacturing

100 F Street, NE

Washington, DC 20549

	Re:	Document Security Systems, Inc.
		Preliminary Proxy Statement on Schedule 14A
		Filed June 19, 2020
		File No. 001-32146

Ladies and Gentlemen:

Document Security Systems, Inc. (the “Company”) is hereby submitting an Amendment to a Preliminary Proxy Statement on a Form PRE 14A (“Submission No. 2”). The Company previously submitted a Preliminary Proxy Statement on Form PRE 14A on June 19, 2020 (“Submission No. 1”). Submission No. 2 has been revised to reflect the Company’s responses to the comment letter to Submission No. 1 received on June 29, 2020 from the staff of the Commission (the “Staff”).

For your convenience, the Staff’s comment contained in the letter has been restated.

Preliminary Proxy Statement on Schedule 14A filed June 19, 2020

General

1.	*Please include the information about the acquired company required pursuant to Item 14(c)(2) of Schedule 14A and Part C, Item 17 of Form S-4. Refer generally to Note A of Schedule 14A.*

Response: The Company respectfully acknowledges the Staff’s comment and has included throughout Submission No. 2 the information about Impact BioMedical, Inc. required pursuant to Item 14(c)(2) of Schedule 14A and Part C, Item 17 of Form S-4.

We hope the foregoing answers are responsive to your comments. Please do not hesitate to contact our counsel, Darrin Ocasio, (212) 398-1493 with any questions or comments regarding this correspondence.

	Sincerely,

	/s/ Frank D. Heuszel
	Frank D .Heuszel

cc: Darrin Ocasio, SRF LLP (via email)